The Achieve-3 trial, funded by Eli Lilly, studied more than 1,500 adults with type 2 diabetes from 131 medical research centres and hospitals in Argentina, China, Japan, Mexico and the US
One does need to increase the dosage slowly, titrating it, under monitoring TSH levels and most importantly, monitoring the patients well-being. Thyroid hormones in excess carry the risk of tachycardia and arrhythmia that is why usually the prohormone T4 and not the active hormone T3 is prescribed and supplemented
We tackle the paperwork and follow-up, making sure you can focus on your weight loss journey
However, the proportion of patients referred to a health care facility increased from 23% to 33.5% over the study period
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Some people need six weeks